Seed · Biotech · Uppsala, Sweden · Founded 2014 · 10–15 employees
Immuneed is a preclinical contract research organization that provides human-relevant immunological assessments for drug developers using their proprietary ID.Flow platform. Their innovative technology uses fresh human whole blood to analyze immune responses that traditional animal models often miss, addressing important questions related to drug safety and immunology. The company was founded in 2014 by Sara Mangsbo from Uppsala University and has raised SEK 4.3M in seed funding. They are at the forefront of New Approach Methodologies (NAMs) that aim to reduce, replace and refine animal studies in pharmaceutical research, recently being featured in Nature Communications for their breakthrough technology.
No open roles listed right now.